Dec 04, 2013 at 13:43 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one may buy NIIT Technologies as the stock is on the verge of making new highs.
Nov 23, 2013 at 16:38 | Source: CNBC-TV18
Malaria vaccine is a good example of the company's broad commitment to innovate and improve access to medicine and healthcare for people. It is not just a programme or a PR campaign, said GSK CEO, Andrew Witty.
Nov 18, 2013 at 10:08 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, auto stocks like Mahindra and Mahindra, Maruti, Escorts, Hero Motocorp and Tata Motors and metal stocks like Tata Steel, Sesa Sterlite, SAIL and JSW Steel will get astrological support.
Nov 12, 2013 at 17:13 | Source: Moneycontrol.com
GlaxoSmithKline Pharmaceuticals has reported a sales standalone turnover of Rs 626.65 crore and a net profit of Rs 100.95 crore for the quarter ended Sep '13
Nov 11, 2013 at 11:04 | Source: Moneycontrol.com
Sales of GlaxoSmithkline Pharmaceuticals are expected to increase by 10.8 percent Q-o-Q (up 5.5 percent Y-o-Y) to Rs 705.4 crore, according to Motilal Oswal.
Nov 07, 2013 at 16:15 | Source: Moneycontrol.com
GlaxoSmithKline Consumer Healthcare has reported a sales standalone turnover of Rs 1,014.08 crore and a net profit of Rs 146.93 crore for the quarter ended Sep '13
Nov 06, 2013 at 08:43 | Source: CNBC-TV18
Maruti Suzuki | Reliance Communications | MphasiS | ONGC | TCS | Bayer Cropscience | State Bank Of Travancore | Scooters India | Financial Technologies | BHEL | Ashok Leyland | Voltas | Thermax and MCX are stocks, which are in the news today.
Oct 25, 2013 at 13:54 | Source: Moneycontrol.com
GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on November 11, 2013, inter alia, to consider approval of unaudited financial results for the quarter ended September 30, 2013 (Q3).
Oct 18, 2013 at 16:46 | Source: PTI
Quoting IMS data, the company said the current total market size of these products in the US is USD 518 million per annum.
Oct 18, 2013 at 13:51 | Source: Moneycontrol.com
Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) approvals from the US Food and Drug Administration (US FDA) for Bupropion Hydrochloride Extended-release Tablets USP (SR), 100 mg, 150 mg and 200 mg, the generic version of GlaxoSmithKlines antidepressant Wellbutrin SR(R).